M
Mitra Rezaei
Researcher at Shahid Beheshti University of Medical Sciences and Health Services
Publications - 45
Citations - 263
Mitra Rezaei is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 35 publications receiving 117 citations. Previous affiliations of Mitra Rezaei include Ardabil University of Medical Sciences & Iran University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
TL;DR: This report reviews what is currently known about the immunologic features including the expression of inflammatory cytokines, chemokines, and lymphocyte subsets in the cases with severe form of COVID-19 and finds changes in peripheral white blood cells and immune cells are found in patients with CO VID-19.
Journal ArticleDOI
Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.
TL;DR: In this article, the authors investigated the characteristics and clinical significance of dynamic changes of lymphocyte subsets in the course of COVID-19 and found an increasing trend in total T cells, T helper, cytotoxic T cells and activated lymphocytes among responders.
Journal ArticleDOI
Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.
Farahnaz Sadegh Beigee,Mihan Pourabdollah Toutkaboni,Neda Khalili,Seyed Alireza Nadji,Atosa Dorudinia,Mitra Rezaei,Elham Askari,Behrooz Farzanegan,Majid Marjani,Amir Rafiezadeh +9 more
TL;DR: This study conducted on 31 deceased patients who were hospitalized for COVID-19 in a tertiary hospital in Tehran, Iran found that lung tissue samples tested positive for SARS-CoV-2 by RT-PCR, and liver specimens mainly showed macrovesicular steatosis, portal lymphoplasmacytic inflammation and passive congestion.
Journal Article
Evaluation of Extended Spectrum Betalactamase(ESBL) Positive Strains of Klebsiella pneumoniae And Escherichia coli in Bacterial Cultures
TL;DR: Investigation of extended spectrum betalactamase positive strains of Klebsiella pneumonia and Escherichia coli in positive bacterial cultures found high incidence of ESBL positive isolates of E. coli and K. pneumonia was high and should be considered in administration of broad-spectrum antibiotics by clinicians.
Journal ArticleDOI
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial.
Atefeh Fakharian,Saghar Barati,Maryam Sadat Mirenayat,Mitra Rezaei,Sara Haseli,Pooria Torkaman,Sahar Yousefian,Alireza Dastan,Hamidreza Jamaati,Farzaneh Dastan +9 more
TL;DR: In this paper, the potential therapeutic role of adalimumab in treating COVID-19 cases in combination therapy with remdesivir and dexamethasone was investigated.